Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.

Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Cancer Patient Care Center.

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.

A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses.

After serving 16 years as associate director for Research Education at Vanderbilt-Ingram Cancer Center (VICC), Ann Richmond, PhD, Ingram Professor of Cancer Research, is stepping down from the leadership post.

"Vanderbilt will always be a place that we hold dear for everything they have done for us,” says Mary Beth Ballard Murray.

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.